Clinical Trial Update: EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer [EARLY_Phase 1]

View source ↗

Summary

This early-phase clinical trial evaluates an EGFR/B7H3-targeted CAR-T cell therapy for advanced lung cancer and advanced triple-negative breast cancer and is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• EGFR/B7H3 CAR-T therapy (CAR-T cells targeting EGFR and B7H3)

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: EGFR/ B7H3-positive Advanced Lung Cancer, EGFR/ B7H3-positive Advanced Triple-negative Breast Cancer | EARLY_Phase 1 | Status: RECRUITING